Serum levels of interleukin- 10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1569-1574

  Kitaoka, Shuji ^a   Shiota, Goshi ^a   Kawasaki, Hironaka ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Hepatitis C virus; Interleukin 10; Interleukin 12; Soluble interleukin 2 receptor

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL;

AGED; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2;

EID: 0141540375     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cerny A, Chisari FV: Immunological aspects if HCV infection. Intervirology 1994; 37:119-125.
2. Tsai SL, Chen PJ, Hwang LH, et al: Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection. J Hepatol 1994; 21:403-411.
3. Napoli J, Bishop AG, McGuinness PH, et al: Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24:759-765.
4. Mosmann TR, Cherwinski H, Bond MW, et al: Two types murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-2357.
5. Fishman MA, Perelson AS: Th1/Th2 cross regulation. J Theor Biol 1994; 70:25-56.
6. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12:227-257.
7. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4008-4027.
8. Wang HM, Smith KA: The interleukin 2 receptor. Functional consequences of its biomolecular structure. J Exp Med 1987; 166:1055-1069.
9. Rubin LA, Jay G, Nelson DL: The released interleukin 2 receptor binds interleukin 2 efficiency. J Immunol 1986; 137:3841-3844.
10. Balderas RS, Josimovic-Alasevic O, Diamantstein T, et al: Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice. J Immunol 1987; 139:1496-1500.
11. Symons JA, Wood NC, DiGiovine FS, et al: Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol 1988; 141:2612-2618.
12. Muller C, Knoflach P, Zielinski CC: Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease. Hepatology 1989; 10:928-932.
13. Davis GL, Hoofnagle JH: Interferon in viral hepatitis: role in pathogenesis and treatment. Hepatology 1986; 6:1038-1041.
14. Davis GL, Balart LA, Schiff ER, et al: Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. N Engl J Med 1989; 321:1502-1506.
15. Higuchi T, Kikuchi M, Okazaki M: Hepatocellular carcinoma after transcatheter arterial embolization. A histopathological study of 84 resected cases. Cancer 1994; 73:2259-2267.
16. Yamazaki H, Nishimoto N, Oi H, et al: Serum interleukin 6 as predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization. Cytokine 1995; 7:191-195.
17. Itoh Y, Okanoue T, Ohnishi N, et al: Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor. Liver 1999; 19:97-103.
18. Cribier B, Schmitt C, Rey D, et al: Production of cytokines in patients infected by hepatitis C virus. J Med Virol 1998; 55:89-91.
19. Kakumu S, Okumura T, Ishikawa M, et al: Serum levels of IL-10, Il-15 and soluble tumor necrosis factor-alfa receptor in type C chronic liver disease. Clin Exp Immunol 1997; 109:458-463.
20. Reiser M, Constantine GM, David R, et al: Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 1997; 26:471-478.
21. Quiroga JA, Martin J, Navas S, et al: Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage. J Inf Dis 1998; 178:247-251.
22. Dumoulins FL, Bach A, Leifeld L, et al: Semiquantitive analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Inf Dis 1997; 175:681-685.
23. Bertoletti A, Delios MM, Boni C, et al: Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112:193-199.
24. Kakamu S, Okumura T, Ishikawa K, et al: Production of interleukin 10 and 12 by peripheral blood mononuclear cells in chronic hepatitis C virus infection. Clin Exp Immunol 1997; 108:138-143.
25. Morishima I, Kumada T, Nakano S, et al: Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-Alpha. Scand J Gastroenterol 1995; 30:807-811.
26. Cacciarelli TV, Martinez OL, Gish RG, et al: Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 1996; 24:6-9.
27. Kuzushita N, Hayashi N, Katayama K, et al: Elevated serum levels of IL-10 in patients with acute and chronic HCV carriers. Hepatology 1995; 22:356A.
28. Rennick D, Davidson A, Berg D: Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol 1995; 76:S174-178.
29. Lentsch AB, Yoshihide H, Kato A, et al: Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 1999; 30:1448-1453.
30. Izzo F, Curley S, Maio P, et al: Correlation of soluble interleukin 2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancer. Surgery 1996; 120:100-105.